An observational study in Tuberculosis, sponsored by Fundació Institut Germans Trias i Pujol. Recruiting at 5 sites in Spain. Per ClinicalTrials.gov, last updated 2024-12-27.
Sponsored by Fundació Institut Germans Trias i Pujol · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 25 studies in Tuberculosis with a site in Spain — 4 open to participants now, 4 under way, none of them phase 3. Tuberculosis · Spain.
Among the 25 studies in Tuberculosis with a site in Spain, this one is one of 2 that started in 2018, is one of 6 observational ones, and was the 15th registered.
1,173 studies on the registry are indexed under Tuberculosis; 177 are open to participants now.
Browse Tuberculosis studies →4 of the 25 studies in Tuberculosis with a site in Spain are open now. Recruiting first, the newest first:
GlaxoSmithKline · Sites in Spain
Ages 18–64 · Women only · Healthy volunteers
Clinica Universidad de Navarra, Universidad de Navarra · Sites in Spain
Ages 50–75 · Healthy volunteers
Fundació Institut Germans Trias i Pujol · Sites in Spain
Healthy volunteers
A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →
Of the 112 Tuberculosis studies recruiting now, 65 (58%) set no upper age limit and 37 (33%) stop at 75 or younger; 49 take children under 18; 31 take healthy volunteers.
This study: all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
25 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 3 · Phase 2 3 · Phase 3 4 · Phase 4 4
First in 1994; this study’s year is marked. 2 started in 2018.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 200 is below the median of 252 across 318 observational studies indexed under Tuberculosis.
Median enrollment 300 across the 19 interventional studies, 583 across the 6 observational. Of the 17 that completed or were terminated, 4 (24%) have results posted.
This tab as a report to print or save as PDF → With an account.
4 of 25 have an industry lead sponsor. The 10 most frequent:
Fundació Institut Germans Trias i Pujol is the lead sponsor of 25 studies on the registry; 9 are open to participants now.
Fundació Institut Germans Trias i Pujol has 7 studies filed under Tuberculosis — fewer than ten, so there is no comparison to draw.
2 of the studies in Tuberculosis with a site in Spain that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT03691883Fundació Institut Germans Trias i PujolDesign of an Integrative Algorithm for Staging Tuberculosis | 2026-12-31 |
| NCT06706596Fundació Institut Germans Trias i PujolA Systemic Screening for TB Disease in High-risk Groups in Barcelona | 2026-12-31 |
Add all 2 to your calendar (.ics) → With an account.
Among the 25 studies in Tuberculosis with a site in Spain, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Tuberculosis is a chronic infectious disease that affects 10 million people, 300 in the city of Barcelona, every year. With serious consequences at public health level, it is associated with other diseases, and generated and influenced by many social and psychological factors. This study aims to stage tuberculosis disease by an integrative approach.
Tuberculosis is a chronic infectious disease that affects 10 million people, there are 300 new cases 300 in the city of Barcelona, every year. Tuberculosis has serious consequences at public health level. It is associated with other diseases, and generated and influenced by many social and psychological factors. This study aims to stage tuberculosis disease by a novel integrative approach.
TB patients which clinical management is done at the following clinical centers: Servicios Clínicos, Hospital Universitari Vall d'Hebron-Drassanes or Hospital Universitari Germans Trias i Pujol.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
TB patients diagnosed and followed-up in Barcelona, at the following Hospitals/Clinics: Servicios Clínicos, Hospital Universitari Germans Trias i Pujol, Hospital Universitari Vall d'Hebron-Drassanes, Hospital del Mar.
Clinical changes
Changes in clinical status
Time frame: timepoints 0 (at inclusion), at month 2 and month 6 (and month 12 if MDR/XDR)
Microbiological changes
Changes in microbiological cultures
Time frame: timepoints 0 (at inclusion), at month 2 and month 6 (and month 12 if MDR/XDR)
Changes in Biomarkers values
Changes in the biomarkers along time assessed by using analyzing parameters in blood and urine samples (by ELISA and LUMINEX)
Time frame: timepoints 0 (at inclusion), at month 2 and month 6 (and month 12 if MDR/XDR)
Radiological Score Value
Changes in the BCN-SA Radiological Score Value. This Score assesses the sum of acute and chronic findings in the chest X-ray. Per each finding, a maximum score of 8 is recorded. The total score value is calculated by adding all the individual findings score values. Higher values of total score represent a worse outcome.
Time frame: timepoints 0 (at inclusion), at month 2 and month 6 (and month 12 if MDR/XDR)
Changes in SGRQ score
Changes in Health Quality of Life measures along time assessed by using the Saint George's Respiratory Questionnaire (SGRQ, numeric score). It measures 3 subscales (symptoms/activity/impacts) and The Total score is calculated by summing all positive responses in the questionnaire and expressing the result as a percentage of the total weight for the questionnaire. Higher values represent a worse outcome.
Time frame: timepoints 0 (at inclusion), at month 2 and month 6 (and month 12 if MDR/XDR)
Changes in Kessler-10 score
Changes in Health Quality of Life measures along time assessed by using the questionnaire Kessler-10 (K10, numeric score). Higher values represent a worse outcome.
Time frame: timepoints 0 (at inclusion), at month 2 and month 6 (and month 12 if MDR/XDR)
Changes in Health Quality of Life measures along time using BCN-Q questionnaire
Changes in Health Quality of Life measures along time using BCN-Q questionnaire (descriptive questionnaire).
Time frame: timepoints 0 (at inclusion), at month 2 and month 6 (and month 12 if MDR/XDR)
Plan to share: Undecided — IPD that underlie results in a publication might be shared with other researchers
Started Apr 2018 (actual). Primary completion is estimated for Dec 2026, 104 months after the start.
Of 123 non-industry observational studies under Tuberculosis, half reached primary completion within 41 months of starting (the median), counting those still running; a quarter within 24 and three quarters within 76. This study's planned 104 months is above that.
Counting every sponsor, half of 135 studies reached it within 36 months; a quarter within 21 and three quarters within 76.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Fundació Institut Germans Trias i Pujol